CD36 and metabolic dysfunction-associated steatohepatitis: These genes are normally expressing at very low levels in the hepatocytes, but CD36 expression increases in NASH patients and VLDLR increases in some pathological conditions, such as obesity, diabetes, and NAFLD [52].